Mangoceuticals, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 0.214095 million compared to USD 0.100722 million a year ago. Net loss was USD 2.37 million compared to USD 2.56 million a year ago.

Basic loss per share from continuing operations was USD 0.1 compared to USD 0.23 a year ago. Diluted loss per share from continuing operations was USD 0.1 compared to USD 0.23 a year ago.